Connect with Nuventra at this year’s BIO Digital Biotech Conference. The virtual meeting will be hosted June 10 – 11 & 14 – 18, 2021.
Nuventra’s team of experienced consultants includes several former FDA Reviewers. Our former FDA reviewers will be available for complimentary 30-minute consultations during the virtual BIO meeting. In this meeting, they can answer questions, offer advice on your regulatory strategy, interpret guidances, and offer their opinions on various clinical pharmacology issues.
Request a meeting with a former FDA reviewer or connect with us via the BIO Partnering Platform.
Meet the Former FDA Reviewers
Suliman Al-Fayoumi, MBA, Ph.D. has over 23 years of experience in regulatory science and the pharmaceutical industry including experience in clinical pharmacology, biopharmaceutics, pharmacology, toxicology and translational sciences. In addition, Dr. Al-Fayoumi spent 8 years as a Senior Clinical Pharmacology and Biopharmaceutics Reviewer at FDA, 4.5 years at Novartis Pharma, and 8 years at two small biotech companies.
Iftekhar Mahmood, Ph.D. has more than 25 years of clinical pharmacology experience at the FDA. Dr. Mahmood worked in both the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER). During this period, Dr. Mahmood worked on neurological products, therapeutic proteins, coagulation factors, and immunoglobulins.
Gene Williams, Ph.D. has over 25 years of experience in clinical pharmacology, 20 of which occurred at the FDA, first as an FDA Primary Reviewer and subsequently as an FDA Team Leader. He has worked on more than 400 different drugs as an FDA Primary Reviewer and 600 as an FDA Team Leader. The majority of his time at the FDA was spent reviewing oncology applications.